×
For best experience we recommend to activate Javascript in your browser.
CTLA4 antibody (AA 41-192)
The Rabbit Polyclonal anti-CTLA4 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect CTLA4 in samples from Rat.
Quick Overview for CTLA4 antibody (AA 41-192) (ABIN7615829)
Target
See all CTLA4 Antibodies
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Reactivity
All reactivities for CTLA4 antibodies
Rat
Host
All hosts for CTLA4 antibodies
Rabbit
Clonality
All clonalities for CTLA4 antibodies
Polyclonal
Conjugate
All conjugates for CTLA4 antibodies
This CTLA4 antibody is un-conjugated
Application
All applications for CTLA4 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CTLA4 Antibody
(hide)
Binding Specificity
All epitopes for CTLA4 antibodies
AA 41-192
Purpose
Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Polyclonal Antibody
Sequence
Thr41~Lys192
Characteristics
The Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CTLA4
(hide)
Target
CTLA4
(Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
Alternative Name
CTLA4
Gene ID
63835
UniProt
Q62859
Pathways
Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat